Coudert G - Search Results

1

Synthesis and biological evaluation of novel naphthocarbazoles as potential anticancer agents.

Routier S, Peixoto P, Mérour JY, Coudert G, Dias N, Bailly C, Pierré A, Léonce S, Caignard DH. Routier S, et al. Among authors: coudert g. J Med Chem. 2005 Mar 10;48(5):1401-13. doi: 10.1021/jm049213f. J Med Chem. 2005. PMID: 15743184

2

DNA interaction and cytotoxicity of a new series of indolo[2,3-b]quinoxaline and pyridopyrazino[2,3-b]indole derivatives.

Arimondo PB, Baldeyrou B, Laine W, Bal C, Alphonse FA, Routier S, Coudert G, Mérour JY, Colson P, Houssier C, Bailly C. Arimondo PB, et al. Among authors: coudert g. Chem Biol Interact. 2001 Oct 25;138(1):59-75. doi: 10.1016/s0009-2797(01)00260-5. Chem Biol Interact. 2001. PMID: 11640915

3

A novel series of 2,6,7-substituted 2,3-dihydro-1,4-benzodioxin and 2,6,7-substituted 1,4-benzodioxin derivatives as lipid peroxidation inhibitors. Structure-activity relationships for high inhibition of human low-density lipoprotein peroxidation.

Thiéry V, Coudert G, Bizot-Espiard JG, Pfeiffer B, Renard P, Lindenbaum A, Guillaumet G. Thiéry V, et al. Among authors: coudert g. J Med Chem. 2001 Nov 8;44(23):3904-14. doi: 10.1021/jm0108045. J Med Chem. 2001. PMID: 11689076

4

Novel 5-azaindolocarbazoles as cytotoxic agents and Chk1 inhibitors.

Lefoix M, Coudert G, Routier S, Pfeiffer B, Caignard DH, Hickman J, Pierré A, Golsteyn RM, Léonce S, Bossard C, Mérour JY. Lefoix M, et al. Among authors: coudert g. Bioorg Med Chem. 2008 May 1;16(9):5303-21. doi: 10.1016/j.bmc.2008.02.086. Epub 2008 Mar 4. Bioorg Med Chem. 2008. PMID: 18342518

5

Synthesis and biological evaluation of novel benzodioxinocarbazoles (BDCZs) as potential anticancer agents.

Ayerbe N, Routier S, Gillaizeau I, Maiereanu C, Caignard DH, Pierré A, Léonce S, Coudert G. Ayerbe N, et al. Among authors: coudert g. Bioorg Med Chem Lett. 2010 Aug 1;20(15):4670-4. doi: 10.1016/j.bmcl.2010.05.088. Epub 2010 May 26. Bioorg Med Chem Lett. 2010. PMID: 20566289

6

New and promising type of leukotriene B4 (LTB4) antagonists based on the 1,4-benzodioxine structure.

Bouissane L, Khouili M, Coudert G, Pujol MD, Guillaumet G. Bouissane L, et al. Among authors: coudert g. Eur J Med Chem. 2023 Jun 5;254:115332. doi: 10.1016/j.ejmech.2023.115332. Epub 2023 Apr 6. Eur J Med Chem. 2023. PMID: 37043995

7

Synthesis and reactivity of imide-derived bisvinyl phosphates. Reactivity of 2,6-disubstituted 1,4-dihydropyridines.

Mousset D, Gillaizeau I, Sabatié A, Bouyssou P, Coudert G. Mousset D, et al. Among authors: coudert g. J Org Chem. 2006 Aug 4;71(16):5993-9. doi: 10.1021/jo0607360. J Org Chem. 2006. PMID: 16872181

8

Easy access to new heterocyclic systems: 1,4-oxazine and substituted 1,4-oxazines.

Claveau E, Gillaizeau I, Blu J, Bruel A, Coudert G. Claveau E, et al. Among authors: coudert g. J Org Chem. 2007 Jun 22;72(13):4832-6. doi: 10.1021/jo070528n. Epub 2007 May 17. J Org Chem. 2007. PMID: 17506583

9

Nucleophilic addition onto methyl-4H-1,4-oxazine-3-carboxylate moiety: short access to 1,4-diazine privileged substructures.

Claveau E, Gillaizeau I, Kalinowska-Tluscik J, Bouyssou P, Coudert G. Claveau E, et al. Among authors: coudert g. J Org Chem. 2009 Apr 3;74(7):2911-4. doi: 10.1021/jo900291f. J Org Chem. 2009. PMID: 19323579

10

Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (I).

Khouili M, Guillaumet G, Coudert G, Pujol MD. Khouili M, et al. Among authors: coudert g. Farmaco. 1996 Mar;51(3):175-84. Farmaco. 1996. PMID: 8688139

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page